Lung Cancer Trial, Recruiting NCT06889467 Sponsor: Barzilai Medical Center Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06889467
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who are strongly suspected of having a type of lung cancer called non-small cell lung cancer (NSCLC), where the cancer may have spread to lymph nodes in the chest, based on medical assessment and imaging scans, and who are scheduled for a procedure to sample those lymph nodes using a specialised bronchoscopy technique (EBUS-TBNA)
  • People whose lymph node samples from that procedure come back negative (meaning no cancer was found in the lymph nodes) and who then go on to need surgery to remove those chest lymph nodes

Who may not be able to join:

  • People who are unable or unwilling to give their consent to take part in the study
  • People whose diagnosis is later confirmed to not be non-small cell lung cancer
  • People who do not end up needing surgery to remove chest lymph nodes, or who will not be having that surgery at the trial's medical centre for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 97285564421

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Barzilai Medical Center
Registry
ClinicalTrials.gov
Start date
20 January 2025
Est. completion
31 December 2025

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

EBUS-TBNA NGS accuracy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov